Novoprotein Scientific Inc. (SHA:688137)
China flag China · Delayed Price · Currency is CNY
113.77
-3.83 (-3.26%)
At close: Nov 17, 2026

Novoprotein Scientific Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
159.32146.44127.56153.19264.55341.9
Revenue Growth
8.14%14.80%-16.73%-42.09%-22.62%90.11%
Gross Profit
85.8571.2554.0882.5210.25287.35
Operating Income
-94.45-92.25-100.31-49.2281.98176.17
Net Income
-96.83-77.78-54.4212.8490.72149.01
Earnings Per Share
-1.40-1.11-0.780.181.593.73
EPS Growth
----88.68%-57.37%-28.67%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
China
141.14
Overseas sales
4.93
Total
146.07

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
725.461,7101,8011,8901,897189.39
Total Debt
48.0355.6166.4273.3183.1587.04
Net Cash (Debt)
677.431,6541,7351,8171,814102.36
Net Cash Growth
-9.77%-4.64%-4.50%0.16%1671.86%9.09%
Net Cash Per Share
9.7723.6124.8725.4631.792.56

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-31.12-13.3613.3269.163.3870.97
Capital Expenditures
-163.94-78.89-44.88-44.94-36.77-69.95
Free Cash Flow
-195.06-92.25-31.5724.22-33.391.02
Free Cash Flow Growth
------98.82%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.89%48.66%42.40%53.85%79.47%84.05%
Operating Margin
-59.28%-63.00%-78.64%-32.13%30.99%51.53%
Pretax Margin
-48.51%-48.06%-42.51%4.06%40.14%51.54%
Profit Margin
-60.77%-53.12%-42.66%8.38%34.29%43.58%
FCF Margin
-122.43%-62.99%-24.75%15.81%-12.62%0.30%

Dividends

Fiscal Year
FY 2023FY 2022
Period EndingDec '23 Dec '22
Dividend Per Share
0.5000.500
Dividend Per Share Growth
0%-
Dividend Yield
0.90%0.66%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---303.1458.79-
P/FCF Ratio
---160.75--
PS Ratio
51.5019.0818.1725.4220.16-